| da1c9f37-779e-4682-816f-93d0faa4cfc9 | nintedanib 150 MG Oral Capsule | SCD | 21 | These highlights do not include all the information needed to use OFEV safely and effectively. See full prescribing information for OFEV. OFEV ® (nintedanib capsules), for oral use Initial U.S. Approval: 2014 | 20251120 |
| da1c9f37-779e-4682-816f-93d0faa4cfc9 | nintedanib 150 MG Oral Capsule | PSN | 21 | These highlights do not include all the information needed to use OFEV safely and effectively. See full prescribing information for OFEV. OFEV ® (nintedanib capsules), for oral use Initial U.S. Approval: 2014 | 20251120 |
| da1c9f37-779e-4682-816f-93d0faa4cfc9 | nintedanib 150 MG (as nintedanib ethanesulfonate 180.6 MG) Oral Capsule | SY | 21 | These highlights do not include all the information needed to use OFEV safely and effectively. See full prescribing information for OFEV. OFEV ® (nintedanib capsules), for oral use Initial U.S. Approval: 2014 | 20251120 |
| 88f8600d-0974-51ca-6f8e-28c48a379e08 | nintedanib 150 MG Oral Capsule | SCD | 4 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20251120 |
| 88f8600d-0974-51ca-6f8e-28c48a379e08 | nintedanib 150 MG (as nintedanib ethanesulfonate 180.6 MG) Oral Capsule | SY | 4 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20251120 |
| 88f8600d-0974-51ca-6f8e-28c48a379e08 | nintedanib 150 MG Oral Capsule | PSN | 4 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20251120 |
| 4d017c42-a823-452d-bc6f-0491dd9823e3 | nintedanib 150 MG Oral Capsule | PSN | 3 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260402 |
| 4d017c42-a823-452d-bc6f-0491dd9823e3 | nintedanib 150 MG Oral Capsule | SCD | 3 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260402 |
| 4d017c42-a823-452d-bc6f-0491dd9823e3 | nintedanib 150 MG (as nintedanib ethanesulfonate 180.6 MG) Oral Capsule | SY | 3 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260402 |
| 43dae004-eaf6-4411-8c3d-db7ab2c3b41e | nintedanib 150 MG Oral Capsule | SCD | 2 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB CAPSULES, for oral use Initial U.S. Approval: 2014 | 20260415 |
| 43dae004-eaf6-4411-8c3d-db7ab2c3b41e | nintedanib 150 MG (as nintedanib ethanesulfonate 180.6 MG) Oral Capsule | SY | 2 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB CAPSULES, for oral use Initial U.S. Approval: 2014 | 20260415 |
| 43dae004-eaf6-4411-8c3d-db7ab2c3b41e | nintedanib 150 MG Oral Capsule | PSN | 2 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB CAPSULES, for oral use Initial U.S. Approval: 2014 | 20260415 |
| 751c3473-35d6-47d6-b405-af16a989716c | nintedanib 150 MG Oral Capsule | PSN | 2 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260120 |
| 751c3473-35d6-47d6-b405-af16a989716c | nintedanib 150 MG (as nintedanib ethanesulfonate 180.6 MG) Oral Capsule | SY | 2 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260120 |
| 751c3473-35d6-47d6-b405-af16a989716c | nintedanib 150 MG Oral Capsule | SCD | 2 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260120 |
| 60d8104e-cb6c-4f4f-8159-95ed57346ffa | nintedanib 150 MG (as nintedanib ethanesulfonate 180.6 MG) Oral Capsule | SY | 1 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260421 |
| 60d8104e-cb6c-4f4f-8159-95ed57346ffa | nintedanib 150 MG Oral Capsule | SCD | 1 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260421 |
| 60d8104e-cb6c-4f4f-8159-95ed57346ffa | nintedanib 150 MG Oral Capsule | PSN | 1 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260421 |
| 4ecf7f05-4a95-b98c-e063-6394a90ab896 | nintedanib 150 MG (as nintedanib ethanesulfonate 180.6 MG) Oral Capsule | SY | 1 | NINTEDANIB CAPSULES. These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB CAPSULES, for oral use Initial U.S. Approval: 2014 | 20260406 |
| 4ecf7f05-4a95-b98c-e063-6394a90ab896 | nintedanib 150 MG Oral Capsule | SCD | 1 | NINTEDANIB CAPSULES. These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB CAPSULES, for oral use Initial U.S. Approval: 2014 | 20260406 |
| 4ecf7f05-4a95-b98c-e063-6394a90ab896 | nintedanib 150 MG Oral Capsule | PSN | 1 | NINTEDANIB CAPSULES. These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB CAPSULES, for oral use Initial U.S. Approval: 2014 | 20260406 |
| b72b26c3-7731-80c0-734b-a5f53a1d89ae | nintedanib 150 MG Oral Capsule | PSN | 1 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260320 |
| b72b26c3-7731-80c0-734b-a5f53a1d89ae | nintedanib 150 MG Oral Capsule | SCD | 1 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260320 |
| b72b26c3-7731-80c0-734b-a5f53a1d89ae | nintedanib 150 MG (as nintedanib ethanesulfonate 180.6 MG) Oral Capsule | SY | 1 | These highlights do not include all the information needed to use NINTEDANIB CAPSULES safely and effectively. See full prescribing information for NINTEDANIB CAPSULES. NINTEDANIB capsules, for oral use Initial U.S. Approval: 2014 | 20260320 |